The aim of this study was to assess the performance of the blood pressure-to-height ratio (BPHR) for screening elevated blood pressure (BP) in children and adolescents using a meta-analysis of eligible published studies. We retrieved studies that investigated the performance of the BPHR for identifying elevated BP from Pubmed and other databases. We performed meta-analyses by subgroups of sex, age and ethnicity using a fixed or random effect model based on whether there was between-study heterogeneity. A total of 13 publications including 262 830 children and adolescents aged 6-18 years on BPHR and a total of three publications including 95 343 children on the modified BPHR were included in this meta-analysis. The summary results suggested that BPHR performed well to identify pre-high BP and high BP for children aged 6-11 years and adolescents aged 12-18 years. The performance of BPHR was perfect for identifying severe high BP in adolescents aged 12-18 years. However, the modified BPHR did not improve accuracy for screening high BP in children aged 6-12 years. In summary, BPHR performed well for identifying elevated BP in children and adolescents, independently of sex, age and ethnicity group. In addition, the modified BPHR performed similarly with BPHR for screening high BP in childhood.Journal of Human
16.3.16
Performance of blood pressure-to-height ratio as a screening tool for elevated blood pressure in pediatric population: a systematic meta-analysis.
The aim of this study was to assess the performance of the blood pressure-to-height ratio (BPHR) for screening elevated blood pressure (BP) in children and adolescents using a meta-analysis of eligible published studies. We retrieved studies that investigated the performance of the BPHR for identifying elevated BP from Pubmed and other databases. We performed meta-analyses by subgroups of sex, age and ethnicity using a fixed or random effect model based on whether there was between-study heterogeneity. A total of 13 publications including 262 830 children and adolescents aged 6-18 years on BPHR and a total of three publications including 95 343 children on the modified BPHR were included in this meta-analysis. The summary results suggested that BPHR performed well to identify pre-high BP and high BP for children aged 6-11 years and adolescents aged 12-18 years. The performance of BPHR was perfect for identifying severe high BP in adolescents aged 12-18 years. However, the modified BPHR did not improve accuracy for screening high BP in children aged 6-12 years. In summary, BPHR performed well for identifying elevated BP in children and adolescents, independently of sex, age and ethnicity group. In addition, the modified BPHR performed similarly with BPHR for screening high BP in childhood.Journal of Human
9.5.15
Brief alcohol interventions for adolescents and young adults: a systematic review and meta-analysis.
J Subst Abuse Treat. 2015 Apr;51:1-18. doi: 10.1016/j.jsat.2014.09.001. Epub 2014Sep 16.Tanner-Smith EE, Lipsey MW.This study reports findings from a meta-analysis summarizing the effectiveness of brief alcohol interventions for adolescents (age 11-18) and young adults (age 19-30). We identified 185 eligible study samples using a comprehensive literature search and synthesized findings using random-effects meta-analyses with robust standard errors. Overall, brief alcohol interventions led to significant reductions in alcohol consumption and alcohol-related problems among adolescents (g = 0.27 and g = 0.19) and young adults (g = 0.17 and g = 0.11). These effects persisted for up to 1 year after intervention and did not vary across participant demographics, intervention length, or intervention format. However, certain intervention modalities (e.g., motivational interviewing) and components (e.g., decisional balance, goal-setting exercises) were associated with larger effects. We conclude that brief alcohol interventions yield beneficial effects on alcohol-related outcomes for adolescents and young adults that are modest but potentially worthwhile given their brevity and low cost.
28.9.14
A GRADE Working Group approach for rating the quality of treatment effect estimates from network meta-analysis.
Network meta-analysis (NMA), combining direct and indirect comparisons, is increasingly being used to examine the comparative effectiveness of medical interventions. Minimal guidance exists on how to rate the quality of evidence supporting treatment effect estimates obtained from NMA.
23.5.14
Meta-analysis of parental protection of children from tobacco smoke exposure.
29.3.14
Meta-analysis of Parental Protection of Children From Tobacco Smoke Exposure.
Which type of sedentary behaviour intervention is more effective at reducing body mass index in children? A meta-analytic review.
21.2.14
School-based obesity prevention programs: a meta-analysis of randomized controlled trials
7.1.14
Effects of daily iron supplementation in primary-school-aged children: systematic review and meta-analysis of randomized controlled trials.
CMAJ. 2013 Nov 19;185(17):E791-802. doi: 10.1503/cmaj.130628. Epub 2013 Oct 15. (Review) PMID: 24130243
BACKGROUND: Anemia is an important public health and clinical problem. Observational studies have linked iron deficiency and anemia in children with many poor outcomes, including impaired cognitive development; however, iron supplementation, a widely used preventive and therapeutic strategy, is associated with adverse effects. Primary-school-aged children are at a critical stage in intellectual development, and optimization of their cognitive performance could have long-lasting individual and population benefits. In this study, we summarize the evidence for the benefits and safety of daily iron supplementation in primary-school-aged children.
METHODS: We searched electronic databases (including MEDLINE and Embase) and other sources (July 2013) for randomized and quasi-randomized controlled trials involving daily iron supplementation in children aged 5-12 years. We combined the data using random effects meta-analysis.
RESULTS: We identified 16 501 studies; of these, we evaluated 76 full-text papers and included 32 studies including 7089 children. Of the included studies, 31 were conducted in low- or middle-income settings. Iron supplementation improved global cognitive scores (standardized mean difference 0.50, 95% confidence interval [CI] 0.11 to 0.90, p = 0.01), intelligence quotient among anemic children (mean difference 4.55, 95% CI 0.16 to 8.94, p = 0.04) and measures of attention and concentration. Iron supplementation also improved age-adjusted height among all children and age-adjusted weight among anemic children. Iron supplementation reduced the risk of anemia by 50% and the risk of iron deficiency by 79%. Adherence in the trial settings was generally high. Safety data were limited.
INTERPRETATION: Our analysis suggests that iron supplementation safely improves hematologic and nonhematologic outcomes among primary-school-aged children in low- or middle-income settings and is well-tolerated.
Comment in
8.9.13
Anaemia, prenatal iron use, and risk of adverse pregnancy outcomes: systematic review and meta-analysis.
BMJ. 2013 Jun 21;346:f3443. doi: 10.1136/bmj.f3443.
Haider BA, Olofin I, Wang M, Spiegelman D, Ezzati M, Fawzi WW; Nutrition Impact
Model Study Group (anaemia).
Comment in
BMJ. 2013;347:f4399.
OBJECTIVES: To summarise evidence on the associations of maternal anaemia and
prenatal iron use with maternal haematological and adverse pregnancy outcomes;
and to evaluate potential exposure-response relations of dose of iron, duration
of use, and haemoglobin concentration in prenatal period with pregnancy outcomes.
DESIGN: Systematic review and meta-analysis
DATA SOURCES: Searches of PubMed and Embase for studies published up to May 2012
and references of review articles.
STUDY SELECTION CRITERIA: Randomised trials of prenatal iron use and prospective
cohort studies of prenatal anaemia; cross sectional and case-control studies were
excluded.
RESULTS: 48 randomised trials (17 793 women) and 44 cohort studies (1 851 682
women) were included. Iron use increased maternal mean haemoglobin concentration
by 4.59 (95% confidence interval 3.72 to 5.46) g/L compared with controls and
significantly reduced the risk of anaemia (relative risk 0.50, 0.42 to 0.59),
iron deficiency (0.59, 0.46 to 0.79), iron deficiency anaemia (0.40, 0.26 to
0.60), and low birth weight (0.81, 0.71 to 0.93). The effect of iron on preterm
birth was not significant (relative risk 0.84, 0.68 to 1.03). Analysis of cohort
studies showed a significantly higher risk of low birth weight (adjusted odds
ratio 1.29, 1.09 to 1.53) and preterm birth (1.21, 1.13 to 1.30) with anaemia in
the first or second trimester. Exposure-response analysis indicated that for
every 10 mg increase in iron dose/day, up to 66 mg/day, the relative risk of
maternal anaemia was 0.88 (0.84 to 0.92) (P for linear trend<0.001). Birth weight
increased by 15.1 (6.0 to 24.2) g (P for linear trend=0.005) and risk of low
birth weight decreased by 3% (relative risk 0.97, 0.95 to 0.98) for every 10 mg
increase in dose/day (P for linear trend<0.001). Duration of use was not
significantly associated with the outcomes after adjustment for dose.
Furthermore, for each 1 g/L increase in mean haemoglobin, birth weight increased
by 14.0 (6.8 to 21.8) g (P for linear trend=0.002); however, mean haemoglobin was
not associated with the risk of low birth weight and preterm birth. No evidence
of a significant effect on duration of gestation, small for gestational age
births, and birth length was noted.
CONCLUSIONS: Daily prenatal use of iron substantially improved birth weight in a
linear dose-response fashion, probably leading to a reduction in risk of low
birth weight. An improvement in prenatal mean haemoglobin concentration linearly
increased birth weight.
PMCID: PMC3689887
PMID: 23794316 [PubMed - indexed for MEDLINE]
17.8.11
Associations between problems with crying, sleeping and/or feeding in infancy and long-term behavioural outcomes in childhood: a meta-analysis.
18.2.11
Interventions to reduce sexual risk for human immunodeficiency virus in adolescents: a meta-analysis of trials, 1985-2008.
DESIGN: We searched electronic databases, leading public health journals, and the document depository held by the Synthesis of HIV/AIDS Risk Reduction Project. Studies that fulfilled the selection criteria and were available as of December 31, 2008, were included.
SETTING: Studies that investigated any behavioral intervention advocating sexual risk reduction for HIV prevention, sampled adolescents (age range, 11-19 years), measured a behavioral outcome relevant to sexual risk, and provided sufficient information to calculate effect sizes.
PARTICIPANTS: Data from 98 interventions (51,240 participants) were derived from 67 studies, dividing for qualitatively different interventions and gender when reports permitted it.
MAIN OUTCOME MEASURES: Condom use, sexual frequency, condom use skills, interpersonal communication skills, condom acquisition, and incident sexually transmitted infections (STIs).
RESULTS: Relative to controls, interventions succeeded at reducing incident STIs, increasing condom use, reducing or delaying penetrative sex, and increasing skills to negotiate safer sex and to acquire prophylactic protection. Initial risk reduction varied depending on sample and intervention characteristics but did not decay over time.
CONCLUSIONS: Comprehensive behavioral interventions reduce risky sexual behavior and prevent transmission of STIs. Interventions are most successful to the extent that they deliver intensive content.
12.7.09
Birth weight, early weight gain, and subsequent risk of type 1 diabetes: systematic review and meta-analysis.
Revisión sistemática y meta-análisis sobre la asociación entre el peso al nacimiento y el aumento de peso durante el primer año de vida y la posterior aparación de diabetes tipo 1.
El peso al nacimiento > 4,000 g se asoció con mayor riesgo de diabetes tipo 1 y en todos los estudios los pacientes con diabetes tipo 1 mostraron una mayor ganancia de peso durante el primer año de vida, en comparación con los controles.
9.11.08
Risk of contralateral testicular cancer among men with unilaterally undescended testis: A meta analysis
Int J Cancer. 2008 Oct 30. [Epub ahead of print]
The association between undescended testis (cryptorchidism) and testicular cancer is established, but it is not known whether the risk of testicular cancer among men with unilateral maldescent is increased in both testes, or only on the undescended side. This is a meta-analysis of 11 case-control studies and 1 cohort study that all assessed the risk of testicular cancer separately for the undescended and descended testis. We used fixed-effects meta-analysis to calculate pooled estimates and 95% confidence intervals (CIs) for the relative risk. Of 199 tumors in men with unilateral cryptorchidism, 158 (79%) were on the ipsilateral side and 41 (21%) on the contralateral side. The pooled relative risks for testicular cancer in the ipsilateral and contralateral testis were 6.33 (95% CI, 4.30 to 9.31) and 1.74 (95% CI, 1.01 to 2.98), respectively. We conclude that in 1-sided undescended testis, the risk of testicular cancer may be increased in both testes, although to a much greater extent on the ipsilateral side.
27.9.07
Child-parent screening for familial hypercholesterolaemia: screening strategy based on a meta-analysis.
BMJ. 2007 Sep 22;335(7620):599. Epub 2007 Sep 13.
Comment in: BMJ. 2007 Oct 6;335(7622):683.
BMJ. 2007 Oct 6;335(7622):683.
BMJ. 2007 Sep 22;335(7620):573-4.
Wald DS, Bestwick JP, Wald NJ.
OBJECTIVE: To develop a population screening strategy for familial hypercholesterolaemia.
DESIGN: Meta-analysis of published data on total and low density lipoprotein (LDL) cholesterol in people with and without familial hypercholesterolaemia according to age. Thirteen studies reporting on 1907 cases and 16 221 controls were used in the analysis. Included studies had at least 10 cases and controls with data on the distribution of cholesterol in affected and unaffected individuals.
MAIN OUTCOME MEASURES: Detection rates (sensitivity) for specified false positive rates (0.1%, 0.5%, and 1%) in newborns and in age groups1-9, 10-19, 20-39, 40-59, and > or =60 years.
RESULTS: Serum cholesterol concentration discriminated best between people with and without familial hypercholesterolaemia at ages 1-9, when the detection rates with total cholesterol were 88%, 94%, and 96% for false positive rates of 0.1%, 0.5%, and1%. The results were similar with LDL cholesterol. Screening newborns was muchless effective. Once an affected child is identified, measurement of cholesterol would detect about 96% of parents with the disorder, using the simple rule thatthe parent with the higher serum cholesterol concentration is the affected parent.
CONCLUSIONS: The proposed strategy of screening children and parents for familial hypercholesterolaemia could have considerable impact in preventing the medical consequences of this disorder in two generations simultaneously.